Roche’s Alecensa backed by China’s National Drug Administration

Approved to treat ALK-positive lung cancer

Original Article: Roche’s Alecensa backed by China’s National Drug Administration

More From BioPortfolio on "Roche’s Alecensa backed by China’s National Drug Administration"